Funding for this research was provided by:
National Cancer Institute (R37 CA25205)
National Cancer Institute (P30 CA015704)
National Science Foundation (IGERT DGE-1258485)
Article History
Received: 25 May 2022
Accepted: 10 November 2022
First Online: 16 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: AHB reports consulting fees from Puma Biotechnology.